1. Home
  2. TECH vs LSCC Comparison

TECH vs LSCC Comparison

Compare TECH & LSCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECH
  • LSCC
  • Stock Information
  • Founded
  • TECH 1976
  • LSCC 1983
  • Country
  • TECH United States
  • LSCC United States
  • Employees
  • TECH N/A
  • LSCC N/A
  • Industry
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • LSCC Semiconductors
  • Sector
  • TECH Health Care
  • LSCC Technology
  • Exchange
  • TECH Nasdaq
  • LSCC Nasdaq
  • Market Cap
  • TECH 8.0B
  • LSCC 8.4B
  • IPO Year
  • TECH 1989
  • LSCC 1989
  • Fundamental
  • Price
  • TECH $50.24
  • LSCC $49.04
  • Analyst Decision
  • TECH Buy
  • LSCC Strong Buy
  • Analyst Count
  • TECH 8
  • LSCC 12
  • Target Price
  • TECH $81.14
  • LSCC $67.08
  • AVG Volume (30 Days)
  • TECH 2.3M
  • LSCC 4.3M
  • Earning Date
  • TECH 05-07-2025
  • LSCC 05-05-2025
  • Dividend Yield
  • TECH 0.64%
  • LSCC N/A
  • EPS Growth
  • TECH N/A
  • LSCC N/A
  • EPS
  • TECH 0.98
  • LSCC 0.44
  • Revenue
  • TECH $1,196,016,000.00
  • LSCC $509,401,000.00
  • Revenue This Year
  • TECH $8.19
  • LSCC $4.46
  • Revenue Next Year
  • TECH $8.85
  • LSCC $20.52
  • P/E Ratio
  • TECH $51.16
  • LSCC $111.45
  • Revenue Growth
  • TECH 4.46
  • LSCC N/A
  • 52 Week Low
  • TECH $46.44
  • LSCC $34.69
  • 52 Week High
  • TECH $85.57
  • LSCC $78.85
  • Technical
  • Relative Strength Index (RSI)
  • TECH 40.99
  • LSCC 51.41
  • Support Level
  • TECH $46.01
  • LSCC $39.60
  • Resistance Level
  • TECH $53.54
  • LSCC $45.22
  • Average True Range (ATR)
  • TECH 3.20
  • LSCC 3.70
  • MACD
  • TECH 0.29
  • LSCC 1.15
  • Stochastic Oscillator
  • TECH 50.84
  • LSCC 97.09

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About LSCC Lattice Semiconductor Corporation

Lattice Semiconductor Corp is a developer of semiconductor technology that it distributes through products, solutions, and licenses. The company reaches its customers through consumer, communications, and industrial markets. The company has one operating segment namely the core Lattice business that includes silicon-based and silicon-enabling products, evaluation boards, development hardware, and related intellectual property licensing, services, and sales. The products of the company are offered globally; and, the majority of sales are derived from customers in Asia. It also has its presence in Americas and Europe.

Share on Social Networks: